Were James Pursley’s Hinge Health (HNGE) share sales made under a Rule 10b5-1 plan?

At least one line of the reported sales was executed under a Rule 10b5-1 plan. A footnote states the sales in that line item were effected pursuant to a trading plan adopted by Pursley on June 13, 2025.

Hinge Health (HNGE) president sells 16,000 shares under Rule 10b5-1 plan

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Hinge Health, Inc. president James Pursley reported selling a total of 16,000 shares of Class A Common Stock in open-market transactions. The sales occurred on May 26, 2026 at weighted average prices of about $53–$55 per share, with individual trades recorded at $53.29, $54.29 and $55.16.

After these transactions, Pursley directly holds 780,223 shares. A footnote explains that at least one line of sales was effected under a Rule 10b5-1 trading plan adopted on June 13, 2025, and that his holdings include 781 shares acquired on May 15, 2026 through the company’s employee stock purchase plan.

Insider Trade Summary 10b5-1

Net Seller: 16,000 shares ($860,606)

Net Sell 3 txns

Insider Pursley James

Role President

Sold 16,000 shs ($861K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	8,995	$53.2927	$479K
Sale	Class A Common Stock	5,905	$54.287	$321K
Sale	Class A Common Stock	1,100	$55.1574	$61K

Holdings After Transaction: Class A Common Stock — 787,228 shares (Direct, null)

Footnotes (1)

The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025. Represents the weighted average sale price. The lowest price at which shares were sold was $52.85 and the highest price at which shares were sold was $53.84. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Includes 781 shares of Class A Common Stock acquired by the Reporting Person on May 15, 2026 pursuant to the Issuer's employee stock purchase plan. Represents the weighted average sale price. The lowest price at which shares were sold was $53.85 and the highest price at which shares were sold was $54.81. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Represents the weighted average sale price. The lowest price at which shares were sold was $54.86 and the highest price at which shares were sold was $55.43. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Key Figures

Total shares sold: 16,000 shares Post-transaction holdings: 780,223 shares Sale price (transaction 1): $55.1574 per share +3 more

6 metrics

Total shares sold 16,000 shares Open-market sales of Class A Common Stock on May 26, 2026

Post-transaction holdings 780,223 shares Directly owned Class A Common Stock after reported sales

Sale price (transaction 1) $55.1574 per share Weighted average sale price for 1,100 shares

Sale price (transaction 2) $54.2870 per share Weighted average sale price for 5,905 shares

Sale price (transaction 3) $53.2927 per share Weighted average sale price for 8,995 shares

ESPP shares included 781 shares Class A shares acquired May 15, 2026 via employee stock purchase plan

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, employee stock purchase plan

3 terms

Rule 10b5-1 trading plan financial

"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"Represents the weighted average sale price. The lowest price at which shares were sold was $52.85"

employee stock purchase plan financial

"Includes 781 shares of Class A Common Stock acquired by the Reporting Person on May 15, 2026 pursuant to the Issuer's employee stock purchase plan"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

Form 4 Insider Transactions: What Each Field Means →

05/27/2026 - 07:14 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pursley James

(Last)

(First)

(Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO

CALIFORNIA

94105

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	05/26/2026		S⁽¹⁾		8,995	D	$53.2927⁽²⁾	787,228⁽³⁾	D
Class A Common Stock	05/26/2026		S⁽¹⁾		5,905	D	$54.287⁽⁴⁾	781,323	D
Class A Common Stock	05/26/2026		S⁽¹⁾		1,100	D	$55.1574⁽⁵⁾	780,223	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025.

2. Represents the weighted average sale price. The lowest price at which shares were sold was $52.85 and the highest price at which shares were sold was $53.84. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

3. Includes 781 shares of Class A Common Stock acquired by the Reporting Person on May 15, 2026 pursuant to the Issuer's employee stock purchase plan.

4. Represents the weighted average sale price. The lowest price at which shares were sold was $53.85 and the highest price at which shares were sold was $54.81. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

5. Represents the weighted average sale price. The lowest price at which shares were sold was $54.86 and the highest price at which shares were sold was $55.43. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

	/s/ James Budge, Attorney-in-Fact	05/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Hinge Health (HNGE) president James Pursley report in this Form 4?

James Pursley reported open-market sales of 16,000 Hinge Health shares. The transactions involved Class A Common Stock sold on May 26, 2026 at prices around $53–$55 per share, and left him holding 780,223 shares directly.

How many Hinge Health (HNGE) shares did James Pursley sell and at what prices?

Pursley sold 16,000 shares of Hinge Health Class A Common Stock. The filing shows weighted average sale prices of $53.29, $54.29 and $55.16 per share, with detailed price ranges provided for each transaction line.

How many Hinge Health (HNGE) shares does James Pursley hold after the reported sales?

After the reported transactions, Pursley directly holds 780,223 shares. This post-transaction balance reflects the effect of the 16,000 shares sold on May 26, 2026 and includes shares acquired through the employee stock purchase plan.

Did James Pursley recently acquire any Hinge Health (HNGE) shares through an employee plan?

Yes, he acquired 781 shares through the employee stock purchase plan. A footnote explains that his reported direct holdings include 781 Class A shares acquired on May 15, 2026 under Hinge Health’s employee stock purchase plan.

What type of transactions are shown in James Pursley’s Hinge Health (HNGE) Form 4?

The Form 4 shows open-market sales of non-derivative Class A Common Stock. All three transactions are coded “S” for sale, classified as non-derivative securities, and are described as sales in open market or private transactions.